Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
JY Wu, SG Wu, CH Yang, YL Chang, YC Chang… - Lung cancer, 2011 - Elsevier
… patients according to different lines of gefitinib or erlotinib. The disparities of choices on gefitinib
or erlotinib (… In conclusion, selecting between erlotinib and gefitinib for treating NSLCL is …
or erlotinib (… In conclusion, selecting between erlotinib and gefitinib for treating NSLCL is …
[HTML][HTML] Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer
YY Shao, CC Lin, CH Yang - Discovery Medicine, 2010 - discoverymedicine.com
… Although both gefitinib and erlotinib target the same EGFR kinase domain, it remains to be …
gefitinib and erlotinib provide the same treatment outcomes in advanced NSCLC patients. For …
gefitinib and erlotinib provide the same treatment outcomes in advanced NSCLC patients. For …
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
… We examined 15 Japanese patients with NSCLC and CNS … -TKI treatment (250 mg daily
gefitinib or 150 mg daily erlotinib) … of the 15 patients received gefitinib and erlotinib treatment; …
gefitinib or 150 mg daily erlotinib) … of the 15 patients received gefitinib and erlotinib treatment; …
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non‑small cell lung cancer in patients with common and rare EGFR gene mutations
P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… no difference in PFS between the erlotinib- and gefitinib-treated groups (11.7 vs. 14.5 …
study of matched Asian patients (121 pairs) with NSCLC (13). These patients were young (median …
study of matched Asian patients (121 pairs) with NSCLC (13). These patients were young (median …
[HTML][HTML] Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment
DH Lee, SW Kim, C Suh, DH Yoon, EJ Yi, JS Lee - Annals of oncology, 2008 - Elsevier
… of erlotinib after failure of gefitinib treatment in patients with non-small-cell lung cancer (NSCLC).
Patients and methods: Patients … on gefitinib treatment were treated with erlotinib 150 mg/…
Patients and methods: Patients … on gefitinib treatment were treated with erlotinib 150 mg/…
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
… The small molecule EGFR TKIs, gefitinib and erlotinib, have both demonstrated antitumor
activity as a single agent in the treatment of patients with advanced NSCLC. Recently, reported …
activity as a single agent in the treatment of patients with advanced NSCLC. Recently, reported …
Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy
… We retrospectively reviewed the records of 467 NSCLC patients who had been treated with
gefitinib or erlotinib at Samsung Medical Center, Seoul, Korea between January 2006 and …
gefitinib or erlotinib at Samsung Medical Center, Seoul, Korea between January 2006 and …
Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe… - Medical oncology, 2013 - Springer
… The gefitinib group included patients treated with gefitinib only … patients who had been
treated with gefitinib prior to erlotinib. The erlotinib group included patients treated with erlotinib …
treated with gefitinib prior to erlotinib. The erlotinib group included patients treated with erlotinib …
[PDF][PDF] Randomized phase III study comparing gefitinib with erlotinib in patients with previously treated advanced lung adenocarcinoma: WJOG 5108L
Y Urata, N Katakami, S Morita, R Kaji… - Journal of Clinical …, 2016 - clf1.medpagetoday.com
… Previously treated patients with lung adenocarcinoma were randomly assigned … gefitinib
or erlotinib. This study aimed to investigate the noninferiority of gefitinib compared with erlotinib. …
or erlotinib. This study aimed to investigate the noninferiority of gefitinib compared with erlotinib. …
[HTML][HTML] Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
Z Song, B Lin, L Shao, Y Zhang - Journal of the Chinese Medical …, 2013 - Elsevier
… We retrospectively reviewed clinical information of patients with ASC who were treated with
gefitinib or erlotinib at Zhejiang Cancer Hospital between January 2007 and December 2011…
gefitinib or erlotinib at Zhejiang Cancer Hospital between January 2007 and December 2011…
相关搜索
- cell lung cancer patients gefitinib therapy
- asian patients gefitinib failure
- erlotinib efficacy gefitinib therapy
- study of erlotinib gefitinib treatment
- erlotinib in patients lung adenosquamous carcinoma
- erlotinib in patients adverse events
- erlotinib in patients previous chemotherapy
- erlotinib in patients randomized phase
- gefitinib erlotinib and afatinib
- erlotinib in patients comparison of gefitinib
- erlotinib in patients study of gefitinib
- patients with lung adenocarcinoma gefitinib therapy
- cerebrospinal fluid concentration gefitinib therapy
- erlotinib in patients cerebrospinal fluid concentration
- leptomeningeal metastases gefitinib therapy
- egfr tyrosine gefitinib therapy